Guangzhou WangLaoJi Great Health Industry Company Limited announced that it will receive CNY 800,000,000 in an equity round of funding from existing investor, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SEHK:874) on January 4, 2017. Post transaction, the company will retain 100% stake in the company. The registered capital of the company will increase from CNY 100,000,000 to CNY 900,000,000. The transaction was approved at the 15th session of the 6th supervisory board meeting and 28th session of the 6th directorate meeting of the investor and does not require the approval of its shareholders.